Biden Admin Promises More ‘Aggressive’ Approach To False Claims Act Enforcement, Lawyers Say

Manufacturers may see a more forceful approach toward False Claims Act enforcement under the new administration, attorneys say.

False Claims Act
• Source: Pharma Intelligence/Alamy

Changes to the US Department of Justice (DOJ) ushered in by President Joe Biden could lead to additional liabilities under the False Claims Act, Gibson Dunn attorneys Jonathan Phillips, Brendan Stewart and Robert Hur said at a 26 October webinar that was part of the firm’s annual series on FCA enforcement.

“It is no big surprise that the Justice Department under the new administration is signaling more aggressive corporate enforcement efforts...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By 

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By 

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.